In this study, additional lncRNAs with biomarker potential in MM were identified (Supplementary Table S1), including 65 antisense genes (e.g., FAM83C-AS1, ZNF32-AS1, TMC3-AS1, and TAT-AS1), 71 lincRNA genes (e.g., LINC00863, LINC01123, LINC00349, LINC00677, and LINC00462) and 25 primary miRNA genes (e.g., MIR301A, MIR378H, MIR425, and MIR647). This evidence concerns the gene TMC3 and Miyoshi myopathy.